Turkish Call For Moves To Support Industry ‘Independence’
Executive Summary
The chairman of Turkey’s main domestic manufacturers’ association has launched some of his strongest criticism yet of multinationals, accusing them of hindering the local sector’s development and calling on the government to support a more independent Turkish industry. The drug trading role of pharmacists has also come in for attack.
You may also be interested in...
Turkey Payer Eyes Foreign Procurement Despite Pharmacist Concerns
As a result of Turkey’s ongoing price control policies, access to new and effective medicines has become difficult in recent years, prompting the country’s medicines payment body to take a new look at taking over the procurement from abroad of unavailable products.
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.
A Bright Moment At Last In Turkish Medtech Debt Payments Saga
Turkish medtechs’ demands for payment of their outstanding hospital debts went unheeded in 2021, but the government has finally started a payment process. It is not evenly applied, and has started in a small way, but the industry feels encouraged on more than one count.